Cargando…

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report

Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Sunil Kumar, Shahi, Arun, Panthi, Ram Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the Nepal Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252234/
https://www.ncbi.nlm.nih.gov/pubmed/35633247
http://dx.doi.org/10.31729/jnma.7081
_version_ 1784740220964438016
author Das, Sunil Kumar
Shahi, Arun
Panthi, Ram Chandra
author_facet Das, Sunil Kumar
Shahi, Arun
Panthi, Ram Chandra
author_sort Das, Sunil Kumar
collection PubMed
description Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and |3-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis.
format Online
Article
Text
id pubmed-9252234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Journal of the Nepal Medical Association
record_format MEDLINE/PubMed
spelling pubmed-92522342022-07-14 Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report Das, Sunil Kumar Shahi, Arun Panthi, Ram Chandra JNMA J Nepal Med Assoc Case Report Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and |3-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis. Journal of the Nepal Medical Association 2022-05 2022-05-31 /pmc/articles/PMC9252234/ /pubmed/35633247 http://dx.doi.org/10.31729/jnma.7081 Text en © The Author(s) 2018. https://creativecommons.org/licenses/by/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Das, Sunil Kumar
Shahi, Arun
Panthi, Ram Chandra
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title_full Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title_fullStr Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title_full_unstemmed Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title_short Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
title_sort recurrent metastatic choriocarcinoma responsive to etoposide and cisplatin with etoposide, methotrexate, and dactinomycin: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252234/
https://www.ncbi.nlm.nih.gov/pubmed/35633247
http://dx.doi.org/10.31729/jnma.7081
work_keys_str_mv AT dassunilkumar recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport
AT shahiarun recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport
AT panthiramchandra recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport